Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
NIH cooperative agreement funding for a single Kidney Precision Medicine Project Central Hub to provide leadership, computational analysis, data management and sharing, communications/outreach, and business operations for the KPMP consortium.
⚑ Clinical Trial Not Allowed · Foreign organizations and foreign components are not allowed · Cooperative agreement with consortium leadership/coordination role
Unit fits — one characterization, each unit's own rules
| Physical Sciences & Engineering (demo) | 90 strong | technical depth: central; funds data infrastructure |
| IPPRA | 58 good | portfolio topic: public_health; social/behavioral work is minor; funds data/survey infrastructure |
| Tom Love Innovation Hub | 15 none | deep-tech content; no commercialization signal |
Description
This Notice of Funding Opportunity (NOFO) requests applications for the Kidney Precision Medicine Project (KPMP) Central Hub (CH) to lead a unified effort to discover and define new acute and chronic kidney disease pathways and subgroups that enable precision clinical trials. The CH will provide strategic leadership for the entire KPMP and steward advanced computational analyses, data management and sharing, communication and outreach, and business operations to realize the vision of the KPMP. All KPMP personnel will actively participate in scientific discovery and promote open science.
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Apply
View on Grants.gov → CONTACT: National Institutes of Health <NIDDK_KUH@nih.gov>
Proposal brief
Proposal shell · National Institutes of Health conventions
Legacy IPPRA LLM assessment (v2.0, for comparison)
18/100 · gpt-5.4-mini · 2026-07-06
This is a biomedical research coordination and data-management hub for kidney disease precision medicine. It has a modest public-health relevance through disease research and dissemination, but it lacks a clear social/behavioral/policy or community-research component that matches IPPRA’s core strengths. Eligibility is restricted to U.S. entities and excludes foreign components, so a public university can apply; however, the fit remains weak for a policy-focused social science institute.
Legacy scoring history
| 2026-07-06 | 18 | gpt-5.4-mini | This is a biomedical research coordination and data-management hub for kidney disease precision medicine. It has a modest public-health relevance through disease research and dissemination, but it lacks a clear social/behavioral/policy or community-research component that matches IPPRA’s core strengths. Eligibility is restricted to U.S. entities and excludes foreign components, so a public university can apply; however, the fit remains weak for a policy-focused social science institute. |
| 2026-07-06 | 18 | gpt-5.4-mini | This is a biomedical precision-medicine coordination and data-management hub focused on kidney disease pathways, with only a limited communication/outreach component and no clear public policy, behavioral, or community-risk dimension that IPPRA typically anchors. A public U.S. university appears eligible to apply, but the opportunity is primarily clinical/technical rather than a strong fit for IPPRA’s social-science and policy portfolio. |